v3.26.1
Organization and Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
Schedule of Accounts Receivable

Accounts receivable consists of the following:

 

   June 30, 2026   December 31, 2025 
   (Unaudited)   (Audited) 
Billed receivable  $280,167   $487,741 
Unbilled receivable   1,022,272    602,556 
Accounts receivable  $1,302,439   $1,090,297 
Schedule of Accounts Payable

Accounts payable consist of the following:

 

 

   June 30, 2026   December 31, 2025 
   (Unaudited)   (Audited) 
Research and development expenses  $467,243   $627,063 
Legal and professional expenses   219,970    133,724 
Other   128,846    91,237 
Accounts payable  $816,059   $852,024 
Schedule of Accrued Expenses

Accrued expenses consist of the following:

   June 30, 2026   December 31, 2025 
   (Unaudited)   (Audited) 
Research and development expenses  $986,346   $493,992 
Employee wages and benefits   362,834    395,459 
Legal expenses   40,000    78,523 
Other   6,500     
Accrued expenses  $1,395,680   $967,974 
Schedule of Research and Development Costs

Research and development costs consist of personnel-related costs, facilities, research-related overhead, services from independent contract research organizations, and other external costs. Research and development costs, for the three and six months ended June 30, 2026 and 2025 were as follows:

   2026   2025   2026   2025 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2026   2025   2026   2025 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Outside contracted services  $174,568   $486,585   $517,289   $842,841 
Personnel related costs   157,757    124,669    271,792    246,385 
Facilities, overhead and other   296    18,125    19,609    35,132 
Research and development costs  $332,621   $629,379   $808,690   $1,124,358